Biomarkers can play a crucial role in de-risking drug development by providing measurable indicators of biological processes associated with disease onset, progression, and treatment response. In this episode of Data Bytes, we spoke with Dr Alexander Koch, Team Lead Bioinformatics at BioLizard, ...
Lausanne (Switzerland) and Ghent (Belgium), April 18, 2024 – BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the appointment of Matthew Hall, PhD, as Director of Business ...
BioLizard’s custom advanced analytics services complement AbnomX’s innovative, user-friendly platform for deciphering immune repertoire data. GHENT, Belgium April 2nd, 2024 - AbnomX and BioLizard announced a strategic partnership today. AbnomX are pioneers in the industrialization of antibody ...
